Leukocytapheresis in ulcerative colitis: A possible alternative to biological therapy?

Digestive and Liver Disease

Volumn 41, Issue 8, 2009, Pages 551-552

  Arseneau, K O ^a   Cominelli, F ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; HEPARIN; INFLIXIMAB; LOW MOLECULAR WEIGHT HEPARIN; MESALAZINE; NAFAMSTAT MESILATE; PLACEBO; TUMOR NECROSIS FACTOR ALPHA;

ADSORPTION; APHERESIS; ARTICLE; BIOLOGICAL THERAPY; CLINICAL TRIAL; COLON RESECTION; CONTROLLED CLINICAL TRIAL; DRUG SAFETY; DRUG TARGETING; FOLLOW UP; GRANULOCYTE; HUMAN; JAPAN; LEUKAPHERESIS; MEDICAL ASSESSMENT; MONOCYTE; PATIENT SAFETY; PLACEBO EFFECT; POSTMARKETING SURVEILLANCE; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RELAPSE; REMISSION; TREATMENT OUTCOME; ULCERATIVE COLITIS; UNSPECIFIED SIDE EFFECT;

COLITIS, ULCERATIVE; GRANULOCYTES; HUMANS; LEUKAPHERESIS; MONOCYTES;

EID: 67649668907     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dld.2009.05.014     Document Type: Note

References (6)

1. Rutgeerts P., Sandborn W.J., Feagan B.G., et al. Infliximab for induction and maintenance therapy for ulcerative colitis. N Engl J Med 353 (2005) 2462-2476
2. Bickston S.J., Lichtenstein G.R., Arseneau K.O., Cohen R.B., and Cominelli F. The relationship between infliximab treatment and lymphoma in Crohn's disease. Gastroenterology 117 (1999) 1433-1437
3. Sands B.E., Sandborn W.J., Feagan B., et al. A randomized, double-blind, sham-controlled study of granulocyte/monocyte apheresis for active ulcerative colitis. Gastroenterology 135 (2008) 400-409
4. Chande N., McDonald J.W., and Macdonald J.K. Unfractionated or low-molecular weight heparin for induction of remission in ulcerative colitis. Cochrane Database Syst Rev (2008) CD006774
5. Bloom S., Kiilerich S., Lassen M.R., et al. Low molecular weight heparin (tinzaparin) vs. placebo in the treatment of mild to moderately active ulcerative colitis. Aliment Pharmacol Ther 19 (2004) 871-878
6. de Bievre M.A., Vrij A.A., Schoon E.J., et al. Randomized, placebo-controlled trial of low molecular weight heparin in active ulcerative colitis. Inflamm Bowel Dis 13 (2007) 753-758